Showing posts with label livestock. Show all posts
Showing posts with label livestock. Show all posts

Sunday, June 7, 2015

Drug Resistance Research: Programming DNA to reverse antibiotic resistance ♦ New target for treating drug-resistant melanoma found ♦ New method may eliminate antibiotic use in livestock ♦

New target for treating drug-resistant melanoma found A new study explains why some melanoma tumors are resistant to BRAF inhibitor treatment. Melanoma is the deadliest form of skin cancer, killing more than 8,000 people in the U.S. each year. Approximately 50 percent of melanoma tumors are driven by mutations in the BRAF gene, and patients with these tumors are prescribed BRAF inhibitors.
High rates of MRSA transmission found between nursing home residents, health care workers Healthcare workers frequently contaminate their gloves and gowns during everyday care of nursing homes residents with drug resistant Staphylococcus aureus or MRSA
New method may eliminate antibiotic use in livestock An animal scientist has developed an antibiotic-free method to protect animals raised for food against common infections. The innovation comes as growing public concern about antibiotic resistance has induced McDonald's, Tyson Foods and other industry giants to announce major cuts in antibiotic use in meat production. About 80 percent of antibiotics in the United States are used by farmers, because they both protect against disease and accelerate weight gain in many farm animals.
Programming DNA to reverse antibiotic resistance in bacteria New research introduces a promising new tool to combat the rapid, extensive spread of antibiotic resistance around the world. It nukes antibiotic resistance in selected bacteria, and renders other bacteria more sensitive to antibiotics. The research, if ultimately applied to pathogens on hospital surfaces or medical personnel's hands, could turn the tide on untreatable, often lethal bacterial infections.

Tuesday, January 28, 2014

2/28/14 Health News: Live Stock Antibiotics are High Risk - FDA bans Product from Indian Plant - Repair Damage from Heart Attacks - Gene Therapy Cures Blindness

NRDC ANALYSIS OF FDA DOCUMENTS FINDS LIVESTOCK ANTIBIOTICS “HIGH RISK” TO HUMANS
According to a safety review conducted by the U.S. Food and Drug Administration, penicillin and tetracycline antibiotic feed additives approved for “nontherapeutic use” do not meet the agency’s current safety standards. In a Natural Resources Defense Council (NRDC) report released today, previously undisclosed FDA documents reveal that none of the 30 products reviewed between 2001... Continue Reading

India's Ranbaxy hit by FDA product ban at 4th Indian plant

Indian drugmaker Ranbaxy Laboratories Ltd faces long delays and high costs in launching big-selling generic drugs in the United States after products from a fourth plant were banned from entering its main market due to manufacturing violations. Continue Reading
New Therapy Tries to Repair Damage in Heart Attacks
In a heart attack, the initial harm is often compounded by a person's immune system, which rushes "soldiers" to the heart to fight what it thinks are invaders. An immune system overreaction also causes much of the trouble in irritable bowel syndrome, multiple sclerosis and West Nile Virus. "The immune system does a significant amount of damage while it's trying to protect us," : Continue Reading
Gene Therapy 'Could Be Used to Treat Blindness'

Surgeons in Oxford have used a gene therapy technique to improve the vision of six patients who would otherwise have gone blind. The operation involved inserting a gene into the eye, a treatment that revived light-detecting cells. The doctors involved believe that the treatment could in time be used to treat common forms of blindness..Continue Reading